SI1951697T1 - Substituirani 5-fenil-3,6-dihidro-2-okso-6h-(1,3,4)tiadiazini - Google Patents
Substituirani 5-fenil-3,6-dihidro-2-okso-6h-(1,3,4)tiadiaziniInfo
- Publication number
- SI1951697T1 SI1951697T1 SI200631094T SI200631094T SI1951697T1 SI 1951697 T1 SI1951697 T1 SI 1951697T1 SI 200631094 T SI200631094 T SI 200631094T SI 200631094 T SI200631094 T SI 200631094T SI 1951697 T1 SI1951697 T1 SI 1951697T1
- Authority
- SI
- Slovenia
- Prior art keywords
- åthiadiazines
- dihydro
- oxo
- phenyl
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/15—Six-membered rings
- C07D285/16—Thiadiazines; Hydrogenated thiadiazines
- C07D285/18—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005055354A DE102005055354A1 (de) | 2005-11-21 | 2005-11-21 | Substituierte 5-Phenyl-3,6-dihydro-2-oxo-6H-[1,3,4]thiadiazine |
| PCT/EP2006/010285 WO2007057092A1 (de) | 2005-11-21 | 2006-10-25 | Substituierte 5-phenyl-3,6-dihydro-2-oxo-6h-[1,3,4]thiadiazine |
| EP06806537A EP1951697B1 (de) | 2005-11-21 | 2006-10-25 | Substituierte 5-phenyl-3,6-dihydro-2-oxo-6h-[1,3,4]thiadiazine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1951697T1 true SI1951697T1 (sl) | 2011-09-30 |
Family
ID=37734761
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200631094T SI1951697T1 (sl) | 2005-11-21 | 2006-10-25 | Substituirani 5-fenil-3,6-dihidro-2-okso-6h-(1,3,4)tiadiazini |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US7902186B2 (sl) |
| EP (1) | EP1951697B1 (sl) |
| JP (1) | JP5334586B2 (sl) |
| KR (1) | KR101424825B1 (sl) |
| CN (1) | CN101312956A (sl) |
| AR (1) | AR058205A1 (sl) |
| AT (1) | ATE517878T1 (sl) |
| AU (1) | AU2006314873B2 (sl) |
| BR (1) | BRPI0618806A2 (sl) |
| CA (1) | CA2630202C (sl) |
| CY (1) | CY1112031T1 (sl) |
| DE (1) | DE102005055354A1 (sl) |
| DK (1) | DK1951697T3 (sl) |
| EA (1) | EA015352B1 (sl) |
| ES (1) | ES2368001T3 (sl) |
| IL (1) | IL191360A (sl) |
| PL (1) | PL1951697T3 (sl) |
| PT (1) | PT1951697E (sl) |
| SI (1) | SI1951697T1 (sl) |
| WO (1) | WO2007057092A1 (sl) |
| ZA (1) | ZA200805406B (sl) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102005055355A1 (de) * | 2005-11-21 | 2007-10-31 | Merck Patent Gmbh | 3,6-Dihydro-2-oxo-6H-[1,3,4]thiadiazinderivate |
| DE102007025718A1 (de) * | 2007-06-01 | 2008-12-04 | Merck Patent Gmbh | Pyridazinonderivate |
| DE102007026341A1 (de) * | 2007-06-06 | 2008-12-11 | Merck Patent Gmbh | Benzoxazolonderivate |
| DE102007032507A1 (de) | 2007-07-12 | 2009-04-02 | Merck Patent Gmbh | Pyridazinonderivate |
| DE102007041115A1 (de) * | 2007-08-30 | 2009-03-05 | Merck Patent Gmbh | Thiadiazinonderivate |
| DE102007061963A1 (de) | 2007-12-21 | 2009-06-25 | Merck Patent Gmbh | Pyridazinonderivate |
| DE102008062826A1 (de) | 2008-12-23 | 2010-07-01 | Merck Patent Gmbh | Pyridazinonderivate |
| DE102009003975A1 (de) * | 2009-01-07 | 2010-07-08 | Merck Patent Gmbh | Benzothiazolonderivate |
| RU2458060C2 (ru) * | 2009-05-22 | 2012-08-10 | Государственное образовательное учреждение высшего профессионального образования "Уральский государственный технический университет - УПИ имени первого Президента России Б.Н. Ельцина" | 5-(4'-гидроксифенил)- и 5-(2',5'-дигидроксифенил)-6н-1,3,4-тиадиазин-2-амины, гидрогалагениды, ингибирующие агрегацию тромбоцитов при внутривенном введении |
| CN111454232B (zh) * | 2020-05-30 | 2021-11-23 | 南方医科大学 | 一种1,3,4-噻二嗪类化合物及其应用 |
| US11351149B2 (en) | 2020-09-03 | 2022-06-07 | Pfizer Inc. | Nitrile-containing antiviral compounds |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19502699A1 (de) * | 1995-01-28 | 1996-08-01 | Merck Patent Gmbh | Arylalkyl-thiadiazinone |
| DE19533975A1 (de) * | 1995-09-14 | 1997-03-20 | Merck Patent Gmbh | Arylalkyl-diazinone |
| GB9525262D0 (en) * | 1995-12-11 | 1996-02-07 | Bayer Ag | Heterocyclylcarbonyl substituted benzofuranyl-ureas |
| DE19604388A1 (de) * | 1996-02-07 | 1997-08-14 | Merck Patent Gmbh | Arylalkyl-diazinone |
| ATE309207T1 (de) * | 1999-08-27 | 2005-11-15 | Sugen Inc | Phosphat-mimetika sowie behandlungsmethoden unter verwendung von phosphatase-inhibitoren |
| DE10150517A1 (de) * | 2001-10-12 | 2003-04-17 | Merck Patent Gmbh | Verwendung von Phosphodiesterase IV-Inhibitoren |
| JP2005515975A (ja) * | 2001-10-31 | 2005-06-02 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | ４型ホスホジエステラーゼ阻害剤およびこれらの使用 |
| ATE480527T1 (de) * | 2001-12-11 | 2010-09-15 | Kyowa Hakko Kirin Co Ltd | Thiadiazolinderivate zur krebsbehandlung |
| DE102005055355A1 (de) * | 2005-11-21 | 2007-10-31 | Merck Patent Gmbh | 3,6-Dihydro-2-oxo-6H-[1,3,4]thiadiazinderivate |
-
2005
- 2005-11-21 DE DE102005055354A patent/DE102005055354A1/de not_active Withdrawn
-
2006
- 2006-10-25 EP EP06806537A patent/EP1951697B1/de active Active
- 2006-10-25 SI SI200631094T patent/SI1951697T1/sl unknown
- 2006-10-25 CN CNA2006800434108A patent/CN101312956A/zh active Pending
- 2006-10-25 CA CA2630202A patent/CA2630202C/en not_active Expired - Fee Related
- 2006-10-25 US US12/094,542 patent/US7902186B2/en not_active Expired - Fee Related
- 2006-10-25 WO PCT/EP2006/010285 patent/WO2007057092A1/de active Application Filing
- 2006-10-25 BR BRPI0618806-0A patent/BRPI0618806A2/pt not_active Application Discontinuation
- 2006-10-25 ES ES06806537T patent/ES2368001T3/es active Active
- 2006-10-25 AT AT06806537T patent/ATE517878T1/de active
- 2006-10-25 JP JP2008540479A patent/JP5334586B2/ja not_active Expired - Fee Related
- 2006-10-25 AU AU2006314873A patent/AU2006314873B2/en not_active Ceased
- 2006-10-25 PL PL06806537T patent/PL1951697T3/pl unknown
- 2006-10-25 PT PT06806537T patent/PT1951697E/pt unknown
- 2006-10-25 EA EA200801365A patent/EA015352B1/ru not_active IP Right Cessation
- 2006-10-25 DK DK06806537.4T patent/DK1951697T3/da active
- 2006-10-25 KR KR1020087014967A patent/KR101424825B1/ko active IP Right Grant
- 2006-11-21 AR ARP060105082A patent/AR058205A1/es not_active Application Discontinuation
-
2008
- 2008-05-12 IL IL191360A patent/IL191360A/en not_active IP Right Cessation
- 2008-06-20 ZA ZA200805406A patent/ZA200805406B/xx unknown
-
2011
- 2011-10-27 CY CY20111101025T patent/CY1112031T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY1112031T1 (el) | 2015-11-04 |
| KR20080070763A (ko) | 2008-07-30 |
| DK1951697T3 (da) | 2011-09-26 |
| PL1951697T3 (pl) | 2011-11-30 |
| KR101424825B1 (ko) | 2014-08-01 |
| EP1951697B1 (de) | 2011-07-27 |
| AU2006314873B2 (en) | 2011-12-08 |
| ES2368001T3 (es) | 2011-11-11 |
| US20080318936A1 (en) | 2008-12-25 |
| AR058205A1 (es) | 2008-01-23 |
| EA200801365A1 (ru) | 2008-10-30 |
| EP1951697A1 (de) | 2008-08-06 |
| CN101312956A (zh) | 2008-11-26 |
| CA2630202A1 (en) | 2007-05-24 |
| US7902186B2 (en) | 2011-03-08 |
| PT1951697E (pt) | 2011-11-04 |
| EA015352B1 (ru) | 2011-06-30 |
| AU2006314873A1 (en) | 2007-05-24 |
| BRPI0618806A2 (pt) | 2011-09-13 |
| ZA200805406B (en) | 2009-11-25 |
| JP2009516657A (ja) | 2009-04-23 |
| ATE517878T1 (de) | 2011-08-15 |
| CA2630202C (en) | 2015-03-31 |
| JP5334586B2 (ja) | 2013-11-06 |
| IL191360A (en) | 2013-10-31 |
| WO2007057092A1 (de) | 2007-05-24 |
| DE102005055354A1 (de) | 2007-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP2108A (en) | Novel biphenylsulfonamides | |
| AP2281A (en) | Novel compounds. | |
| SI1951697T1 (sl) | Substituirani 5-fenil-3,6-dihidro-2-okso-6h-(1,3,4)tiadiazini | |
| EP1830858A4 (en) | 3,6-BICYCLOLIDE | |
| AP2337A (en) | Motilide compounds. | |
| GB0507114D0 (en) | No 1 timemachine | |
| IL184677A0 (en) | Substituted 1,1,1-trifluoro-3-[(benzyl)- | |
| IL182538A0 (en) | 1,5-diheterocycle-1h-triazole derivative | |
| GB0502992D0 (en) | The ballcaster | |
| EP1906960A4 (en) | NEW COMBINATION 1 | |
| GB0425572D0 (en) | 1,7-Naphthyridines | |
| GB0509703D0 (en) | Hayfit 2 | |
| IL188111A0 (en) | 2,5-bis-diamimne [1,4] benzoquinone-derivatives | |
| IL194972A0 (en) | 2-alkoxy-3,4,5-trihydroxy-alkylamide- | |
| IL186226A0 (en) | (3,4-dihydro-quinazolin-2-yl)-indan-1-yl-amines | |
| GB0514559D0 (en) | Qmaster 2005 | |
| GB0510207D0 (en) | Novel combination | |
| EP1940415A4 (en) | 19,23,24,25,26,27-HEXANOR-1ALPHA-HYDROXYVITAMINE D3 | |
| GB0504761D0 (en) | Alfatie, Coliawel, Omaatie | |
| GB0503125D0 (en) | Novel uses | |
| GB0503128D0 (en) | Novel Uses | |
| GB0503124D0 (en) | Novel uses | |
| GB0512288D0 (en) | iCorcost 1 | |
| GB0518747D0 (en) | Zcdemo 14/9/05 | |
| GB0512493D0 (en) | iCorcost 5 |